Proffered Papers - Hepatitis Treatment and Its Impact (Epi, Public Health & Prevention Theme)
Tracks
.
Tuesday, August 14, 2018 |
2:00 PM - 3:30 PM |
City Room 2 (Level 1) |
Speaker
Ms Jane Costello
Research and Program Manager
Kirby Institute, UNSW Sydney
Ongoing Burden Of Advanced Liver Disease Complications Despite Rapid Hcv Treatment Scale-Up
2:00 PM - 2:15 PMBiography
Amy works in Surveillance and Evaluation and Research Program in the Kirby Institute, and previously worked on modelling HIV and hepatitis C among PWID in Australia. Her work focused on using models to understand the epidemiology of HIV and HCV among these populations and assessing the cost-effectiveness of prevention programs
Ms Jennifer MacLachlan
Epidemiologist
WHO Collaborating Centre For Viral Hepatitis
Narantuya Jadambaa
Progress Towards Hepatitis Elimination In Mongolia: Initial Outcomes Of The Healthy Liver National Program 2017-2020
2:30 PM - 2:45 PMBiography
Oyuntuya grew up in eastern Mongolia where many public health issues were part of her childhood. She started public health career as a hospital physical therapist. She pursued a Master's degree at Groningen University. Her research focused on the effects of extreme air pollution on childhood illness and quality eduction.
Dr Evan Cunningham
Postdoctorral Fellow
The Kirby Institute, UNSW
Recurrent Viraemia Following Successful Hcv Daa Therapy Among People With Recent Injecting Drug Use: The Simplify And D3feat Studies
2:45 PM - 3:00 PMBiography
Evan obtained his PhD a the University of New South Wales in Sydney looking at HCV transmission and treatment among people who inject drugs. He is is now working as a postdoctoral fellow in the Viral Hepatitis research Program at the Kirby Institute in Sydney.
Miss Louise Geddes
PhD Student
The Kirby Institute
Accessing Hepatitis C Treatment In New South Wales: Where Are People Who Inject Drugs Being Treated?
3:00 PM - 3:05 PMBiography
Louise Geddes is a Research Assistant and PhD candidate at the Kirby Institute, UNSW. Louise currently works on New South Wales NSP Enhanced Data Collection project which collects data from NSP attendees in NSW. Her particular research interest is opioid use among people who inject drugs.
Dr Jasmine Yee
Clinical Project Coordinator
The Kirby Institute, UNSW
High Efficacy Of Direct-Acting Antiviral Therapies For Hepatitis C Following Universal Access In Australia: The REACH-C Cohort
3:05 PM - 3:20 PMBiography
Jasmine is a Clinical Project Coordinator at The Kirby Institute, with research interests in HCV epidemiology and therapeutic interventions.
Dr Marianne Martinello
Lecturer
The Kirby Institute, UNSW
Universal Access To DAA Therapy Paves The Way For HCV Control And Elimination Among People Living With HIV In Australia
3:20 PM - 3:25 PMBiography
Dr Marianne Martinello is an Infectious Diseases Physician at Blacktown Mt Druitt Hospital and a lecturer in the Viral Hepatitis Clinical Research Program at the Kirby Institute.
Mr Tom Wright
Harm Reduction Project Officer
Justice Health & Forensic Mental Health Network
Reviewing Harm Reduction Strategies in NSW Prisons: A Collaborative Approach to Reduce Transmission of Blood Borne Viruses and Sexually Transmissible Infections
3:25 PM - 3:30 PMBiography
Tom has worked across a number of different organisations providing health education and support services to high risk population groups, currently as Harm Reduction Project Officer, Population Health with Justice Health & Forensic Mental Health Network. Tom holds a Bachelor Arts in Psychology and Philosophy from Sydney University.
Chair
Samuel Elliott
GP
Mitcham General Practice
Alisa Pedrana
Senior Research Fellow
Burnet Institute